Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
414 studies found for:    Open Studies | "Retinal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol 0.2% eye drops
22 Recruiting Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Condition: Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, Intravitreal Bevacizumab
Intervention: Drug: Intravitreal bevacizumab
23 Recruiting Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey
Condition: Retinopathy of Prematurity
Intervention:
24 Recruiting Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants
Condition: Retinopathy of Prematurity
Interventions: Other: RETCAM;   Biological: Blood samples
25 Recruiting Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
Conditions: Diabetes;   Retinal Disorders
Intervention: Device: Pupillometry testing.
26 Recruiting Color Vision as a Measure for Inherited Retinal Diseases
Conditions: Healthy Volunteer;   Retinal Disease;   Inherited Retinal Degeneration
Intervention:
27 Recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
28 Recruiting A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Condition: Non-Proliferative Diabetic Retinopathy
Interventions: Drug: 1.0mg Luminate®;   Drug: 2.0mg Luminate®;   Drug: 3.0mg Luminate®;   Other: Balanced Salt Solution for intravitreal injection in 0.10cc
29 Recruiting CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
Conditions: Diabetic Retinopathy;   Sleep Apnea
Interventions: Device: Continuous positive airway pressure;   Drug: Pharmacological treatment;   Other: Conventional anti-diabetic diet recommendations
30 Recruiting Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Omegaven
31 Recruiting National Eye Institute Biorepository for Retinal Diseases
Conditions: Age-Related Macular Degeneration;   Diabetic Retinopathy;   Von Hippel-Lindau Syndrome;   Retinal Disease;   Retinal Vein Occlusion
Intervention:
32 Recruiting Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
Conditions: Genotype;   Retinal Disease
Intervention:
33 Not yet recruiting Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)
Condition: Retinal Disease
Intervention: Device: optical coherence tomography angiography
34 Recruiting Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)
Conditions: Vitreous Diseases;   Retinal Diseases;   Choroidal Diseases
Intervention: Device: Swept-source optical coherence tomography (SS-OCT)
35 Recruiting Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
Condition: Severe Non-proliferative Diabetic Retinopathy
Interventions: Radiation: T-PRP;   Radiation: S-PRP
36 Recruiting 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
37 Recruiting Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Procedure: Endolaserless Vitrectomy
38 Recruiting Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
39 Recruiting A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: 2% OC-10X;   Drug: Placebo Comparator
40 Recruiting Rainbow Extension Study
Condition: Retinopathy of Prematurity
Intervention: Drug: Ranibizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.